The weekly litigation news digest is live. Subscribe now

IP Verse

Factor Ix Polypeptide Mutant, Its Uses And A Method For Its Production - EP4032979

The patent EP4032979 was granted to Uniqure Biopharma on May 1, 2024. The application was originally filed on Sep 15, 2009 under application number EP21200005A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4032979

UNIQURE BIOPHARMA
Application Number
EP21200005A
Filing Date
Sep 15, 2009
Status
Granted And Under Opposition
Mar 29, 2024
Publication Date
May 1, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

PFIZERJan 31, 2025PFIZERWITHDRAWN

Patent Citations (5) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
OPPOSITIONEP3581650
OPPOSITIONUS2008167219
OPPOSITIONUS4994371
OPPOSITIONWO9903496
SEARCHWO9903496

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents